Subscribe to RSS - ResMed


ResMed gets revenue lift from Brightree


SAN DIEGO – ResMed reported revenues of $465.4 million for the first quarter of fiscal year 2017, a 13% increase compared to the same period the previous year.

Excluding Brightree’s contribution, revenues were $432.4 million, a 5% increase.

Study shows self-monitoring tools make a difference, ResMed says


LOS ANGELES – More than 87% of CPAP users were compliant with their therapy when they used ResMed’s myAir and were monitored with AirView, according to the results of a study that will be presented at the CHEST annual meeting on Oct. 26.

In brief: Utilization drops in Round 2 bid areas, retail finalists named


WASHINGTON – The number of Medicare beneficiaries receiving DMEPOS in Round 2 areas decreased more than twice as much from 2012 to 2014 than in non-bid areas, according to a new report from the Government Accountability Office.

ResMed, Dr. Oz determine America’s ‘sleep score’


SAN DIEGO – ResMed is teaming up with “The Dr. Oz Show” to launch a campaign to foster better public understanding of sleep health. As part of the campaign, which kicks off on the Oct.

ITC to investigate Fisher & Paykel


AUCKLAND, New Zealand – The International Trade Commission plans to investigate certain sleep apnea devices manufactured by Fisher & Paykel, it announced Sept. 19.

ResMed recalls vents in Australia


SAN DIEGO – ResMed, in consultation with the Australian Government Department of Health Therapeutic Goods Administration, has initiated a product correction recall in that country for its Astral 100 and Astral 150 ventilators due to an internal battery issue.

ResMed documents family’s travel with vents


SAN DIEGO – ResMed has produced a documentary film featuring a family that decides to continue to travel and enjoy the outdoors despite having two children living with Duchenne muscular dystrophy (DMD).

ResMed: ‘We’re committed to compliance’


SAN DIEGO – Will ResMed become the second major manufacturer to get a slap on the wrist from the government for its resupply program?

In brief: Drive explains sale, ResMed and F&P trade lawsuits


PORT WASHINGTON, N.Y. – Drive Medical has sent a letter to its customers in response to reports that private equity firm Clayton, Dubilier & Rice is close to buying the company.

ResMed under investigation


SAN DIEGO – ResMed in July received a federal administrative subpoena from the Office of Inspector General requesting documents and other information related to its patient resupply software.